Subscribe to our Newsletters !!
There is one fact about life on Earth we cannot es
In biological research, especially in areas such a
The Nobel Prize in Physiology or Medicine awarded
In today’s rapidly evolving bioprocessing landsc
By the end of 2025, the pharma, laboratory, and an
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of The Magazine
Russia begins Phase III trials of a second possible vaccine against COVID-19, developed by Siberia’s Vector Institute, in November-December, the TASS news agency cited Russian consumer security watchdog Rospotrebnadzor as saying on October 2.
Early-stage clinical trials for the vaccine have been completed on Wednesday.
